Table 6.

Quality assessment of clinical trials (36, 37).

Corresponding author	Was the research described as randomize?	Was the approach of randomization appropriate?	Was the research described as blinding?a	Was the approach of blinding appropriate?	Was there a presentation of withdrawals and dropouts?	Was there a presentation of the inclusion/ exclusion criteria?	Was the approach used to assess adverse effects described?	Was the approach of statistical analysis described?	Total score
Vinogradov et al. (53)	+1	0	0.5	0	+1	0	0	+1	3.5
Hitri et al. (52)	+1	0	0	0	0	0	+1	+1	3

^aSingle-blind get 0.5 score and Double-blind get +1 score.